Literature DB >> 18714314

Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice.

S-M Huang, R Temple.   

Abstract

Mesh：

Year:  2008        PMID： 18714314     DOI： 10.1038/clpt.2008.144

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  44 in total

1.  Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.

Authors:  Ryoichi Yano; Aya Konno; Kyohei Watanabe; Hitoshi Tsukamoto; Yuichiro Kayano; Hiroaki Ohnaka; Nobuyuki Goto; Toshiaki Nakamura; Mikio Masada
Journal:  Int J Clin Oncol       Date:  2011-11-18       Impact factor: 3.402

Review 2.  The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).

Authors:  Larry Tremaine; William Brian; Terrye DelMonte; Stephan Francke; Peter Groenen; Keith Johnson; Lei Li; Kimberly Pearson; Jean-Claude Marshall
Journal:  Pharmacogenomics       Date:  2015-11-30       Impact factor: 2.533

Review 3.  Predicting drug-drug interactions: an FDA perspective.

Authors:  Lei Zhang; Yuanchao Derek Zhang; Ping Zhao; Shiew-Mei Huang
Journal:  AAPS J       Date:  2009-05-06       Impact factor: 4.009

Review 4.  Pharmacogenomic discovery using cell-based models.

Authors:  Marleen Welsh; Lara Mangravite; Marisa Wong Medina; Kelan Tantisira; Wei Zhang; R Stephanie Huang; Howard McLeod; M Eileen Dolan
Journal:  Pharmacol Rev       Date:  2009-12       Impact factor: 25.468

Review 5.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 6.  Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.

Authors:  L V Kalman; Jag Agúndez; M Lindqvist Appell; J L Black; G C Bell; S Boukouvala; C Bruckner; E Bruford; K Caudle; S A Coulthard; A K Daly; Al Del Tredici; J T den Dunnen; K Drozda; R E Everts; D Flockhart; R R Freimuth; A Gaedigk; H Hachad; T Hartshorne; M Ingelman-Sundberg; T E Klein; V M Lauschke; D R Maglott; H L McLeod; G A McMillin; U A Meyer; D J Müller; D A Nickerson; W S Oetting; M Pacanowski; V M Pratt; M V Relling; A Roberts; W S Rubinstein; K Sangkuhl; M Schwab; S A Scott; S C Sim; R K Thirumaran; L H Toji; R F Tyndale; Rhn van Schaik; M Whirl-Carrillo; Ktj Yeo; U M Zanger
Journal:  Clin Pharmacol Ther       Date:  2015-11-20       Impact factor: 6.875

7.  Racial and Ethnic Disparities in Treatment Outcomes of Patients with Ruptured or Unruptured Intracranial Aneurysms.

Authors:  Hind A Beydoun; May A Beydoun; Alan B Zonderman; Shaker M Eid
Journal:  J Racial Ethn Health Disparities       Date:  2018-09-27

8.  If We Would Only Ask: How Henrietta Lacks Continues to Teach Us About Perceptions of Research and Genetic Research Among African Americans Today.

Authors:  Bridgette L Jones; Carrie A Vyhlidal; Andrea Bradley-Ewing; Ashley Sherman; Kathy Goggin
Journal:  J Racial Ethn Health Disparities       Date:  2016-09-23

9.  Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.

Authors:  Sijie Lu; R A Nand; J S Yang; Gang Chen; A S Gross
Journal:  Eur J Clin Pharmacol       Date:  2017-11-27       Impact factor: 2.953

Review 10.  Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.

Authors:  Peter H O'Donnell; M Eileen Dolan
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.